pharmaceutical-investing La Jolla Pharmaceutical Company Gets European Commission Approval for GIAPREZA
pharmaceutical-investing Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
pharmaceutical-investing Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET®
pharmaceutical-investing Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA
pharmaceutical-investing Yescarta (Axicabtagene Ciloleucel) Receives European Marketing Authorization for the Treatment of Relapsed or Refractory DLBCL and PMBCL
pharmaceutical-investing Eisai and Merck Announce European Commission Grants Marketing Authorization for LENVIMA (lenvatinib) as First-Line Treatment in Adults with Advanced or Unresectable Hepatocellular Carcinoma
